← Back to Search

Nurse-Led Telemonitoring for Chronic Conditions

N/A

Recruiting

Led By Emily Seto, PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must have been discharged from hospital within 2 weeks during their recruitment into the study (or will be recruited prior to their discharge)

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up over 30 days, at 6 months, and at 1-year follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial will help bridge the gap in treatment of seniors with multiple chronic conditions by introducing nurse-led integrated care model & telemonitoring to improve coordination & self-care.

Who is the study for?

The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.

What is being tested?

This study tests the SMaRT Clinic model which uses nurse-led care coordinated through telemonitoring to manage patients with multiple chronic conditions after they leave the hospital. It aims to improve self-care education and clinical coordination across patient care teams.

What are the potential side effects?

Since this trial involves a healthcare service intervention rather than medication, traditional side effects are not applicable. However, participants may experience issues related to using technology such as privacy concerns or technical difficulties.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was discharged from the hospital less than 2 weeks ago or will be before joining the study.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ over 30 days, at 6 months, and at 1-year follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~over 30 days, at 6 months, and at 1-year follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and over 30 days, at 6 months, and at 1-year follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Death and/or all-cause unplanned readmission

Secondary study objectives

All-cause mortality

Days alive and out-of-hospital

Readmissions

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Telemonitoring (Medly MCC)Experimental Treatment1 Intervention

Medly is a smartphone application allows patients with heart failure, diabetes, depression, hypertension, and/or COPD to measure and record their daily self-reported symptoms. This monitoring information is then transmitted wirelessly to a data server where an algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated self-care message based on their measurements and reported symptoms.

Group II: ControlActive Control1 Intervention

Control groups will be compared to 350 patients who received standard of care via propensity-matched controls from the ICES provincial database.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Medly

2016

N/A

~100

0 / 2Eligibility criteria met